Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by lou64on Sep 20, 2023 10:42am
167 Views
Post# 35645281

Gotta hurt the bottom line

Gotta hurt the bottom line

Denmark has destroyed more than 145,000 kilograms of cannabis 

 

Tickets for MJBizCon 2023 in Las Vegas are on sale now! Dare to grow and discover the business solutions to elevate your cultivation operation. Buy your ticket.


Image of colorful houses at Nyhavn in Copenhagen, Denmark, with boats in foreground

(Photo by Horvth Botond/stock.adobe.com)

Much of the medical cannabis produced under Denmark’s regulatory system has not made it to market and was intentionally destroyed for various reasons, according to government data.

Just over 300 permits have been issued for the destruction of 145,541 kilograms (320,862 pounds) of cannabis, the Danish Parliament’s Health Committee said in a reply to a parliamentary inquiry earlier this year.

The figure includes all cannabis destroyed by the companies with an authorization to cultivate cannabis – within the country’s pilot program – from the date the businesses secured approval to operate, a government spokesperson told MJBizDaily via email.

The data indicates the amount of legal cannabis destroyed under Denmark’s nearly 6-year-old medical pilot program surpassed the nation’s total marijuana output reported to global drug regulators.

A list of companies currently authorized to manufacture cannabis bulk and primary products is available here. The list includes units of Canada’s Aurora Cannabis and Australia’s Little Green Pharma as well as Medican, a medical marijuana company headquartered in Helsinge, Denmark.

The Danish medical cannabis pilot program came into force in 2018.

The destroyed cannabis is equivalent in weight to roughly 79 Tesla Model Y vehicles.

The numbers underscore that a significant amount of legal cannabis grown in certain countries is never sold for various reasons – such as poor quality, regulatory factors or insufficient demand – and is subsequently destroyed.

In Canada, for example, licensed Canadian companies destroyed a whopping 872,443 kilograms of cannabis between 2018 and 2021.

In Denmark, several types of cultivation authorizations exist. They include:

  • The country’s medical cannabis pilot program.
  • The manufacture of active substances for pharmaceutical products.
  • Plant propagation.
  • The so-called “development” program, which permits companies to grow medical cannabis so they can hone their cultivation and manufacturing methods and be permitted to participate in the nation’s pilot scheme. The cannabis cannot be sold and must be destroyed.

What led to destruction

“All four types of cultivation are licensed and the companies produce and destroy cannabis,” the Danish Medicines Agency spokesperson told MJBizDaily.

“As our destruction procedures are not specific for the cultivation purpose or origin,” the destroyed quantity may include cannabis cultivated for the pilot program, imported for the pilot program as well as cannabis cultivated under the development scheme, the spokesperson said.

While the government can’t say why the cannabis was destroyed, the reply to the parliamentary inquiry noted that the destruction figure could include faulty or discarded products and all cannabis grown under the development program.

The destroyed quantity is expressed in kilograms of dried weight, and companies use a conversion factor if the destroyed product was an extract.

It also includes all cannabis containing more than 0.2% THC.

The spokesperson said a year-by-year comparison of the destruction data was not available.

2022 destruction data

However, a partial figure for 2022 was shared with MJBizDaily.

The Danish Medicines Agency reported that, for 2022, “lost or destroyed” cannabis amounted to 10,753 kilograms – an amount that doesn’t include marijuana destroyed under the development program.

It’s not clear why the amount of destroyed cannabis in Denmark is significantly higher than the amount of cannabis production reported to the International Narcotic Control Board (INCB), the United Nations body for the implementation of the U.N.’s international drug control conventions.

The quantity of cannabis produced in Denmark under the country’s pilot program, according to INCB figures, was:

  • 2,112 kilograms in 2019.
  • 6,587 kilograms in 2020.
  • 32,433 kilograms in 2021.

The figure is not available yet for 2022.

A separate parliamentary inquiry asked for the number of companies approved to grow medical cannabis in Denmark.

In its answer, the Danish Parliament’s Health Committee said only nine companies had permission to grow medical cannabis either for the pilot program, the manufacture of pharmaceutical products or plant propagation.

In addition, 19 companies had active permits to grow cannabis under the development program.

Overall sales of all cannabis products in Denmark grew from about 30.8 million Danish kroner ($4.4 million) in 2020 to 64.3 million kroner in 2021.

Last year, companies in Denmark recorded sales of roughly 62.5 million kroner.

  Liste over virksomheder, der er indehaver af tilladelse til fremstilling af cannabisbulk og cannabisudgangsprodukter - Opdateret den:    
    20/09/2023
                 
    Virksomheds-ID Virksomhedsnavn
Autorisations-nr.
Gldende fra Gldende til      
    274010 Aurora Nordic Cannabis A/S 102414 22-03-2023        
    324912 DanCann Pharma A/S 101485 19-12-2022        
    323742 Little Green Pharma Denmark ApS 102206 01-11-2022        
    274987 MEDICAN A/S 102514 03-04-2023        
    264859 Movianto Nordic ApS 102569 11-08-2023        
    274258 Schroll Medical ApS 102936 11-08-2023        
    13955 Sterigenics Denmark A/S 102335 10-01-2023        
    277953 Tetra Pharm Technologies ApS 102349 03-04-2023        
    323541 Valcon Medical A/S 102495 04-04-2023        
    327815 Valeos Pharma A/S 102336 03-03-2023        
    276620 Vertanical Denmark ApS 102419 24-02-2023        
    11  

<< Previous
Bullboard Posts
Next >>